Metoprolol for hypertension. Open trial in general practice

Area of Science:

• Cardiology
• Pharmacology
• General Practice

Background:

• Hypertension management requires effective and compliant treatment regimens.
• Metoprolol is a common beta-blocker used for hypertension.
• Improving patient compliance and reducing healthcare costs are key objectives in chronic disease management.

Purpose of the Study:

• To evaluate the efficacy and tolerability of a once-daily metoprolol dosage in mild to moderate hypertension.
• To assess the impact of once-daily dosing on patient compliance and treatment expense.
• To identify factors influencing treatment response and side effect occurrence.

Main Methods:

• An uncontrolled, open-label study involving 161 patients with mild to moderate hypertension.
• Patients were administered a once-daily dosage of metoprolol (Betaloc).
• Data collected on treatment efficacy, patient compliance, side effects, and reasons for withdrawal.

Main Results:

• Out of 161 participants, 144 completed the trial.
• Hypertension was controlled in 84 patients; 33 did not respond to therapy.
• 27 patients discontinued due to side effects, with older patients experiencing more adverse events. Efficacy was not sex-dependent.

Conclusions:

• Once-daily metoprolol is a viable option for managing mild to moderate hypertension, potentially improving compliance.
• Treatment response and side effect profiles may vary based on patient age.
• Further research could explore optimizing metoprolol dosing strategies for specific patient demographics.